Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Depreciation & Amortization (CF) (2017 - 2025)

Catheter Precision (VTAK) has disclosed Depreciation & Amortization (CF) for 9 consecutive years, with $528000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) changed 0.38% to $528000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.1 million, a 1.15% increase, with the full-year FY2024 number at $2.1 million, up 1.64% from a year prior.
  • Depreciation & Amortization (CF) was $528000.0 for Q3 2025 at Catheter Precision, roughly flat from $529000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.4 million in Q1 2023 to a low of -$406000.0 in Q2 2023.
  • A 5-year average of $408315.8 and a median of $517000.0 in 2023 define the central range for Depreciation & Amortization (CF).
  • Biggest YoY gain for Depreciation & Amortization (CF) was 1968.0% in 2023; the steepest drop was 398.53% in 2023.
  • Catheter Precision's Depreciation & Amortization (CF) stood at $315000.0 in 2021, then tumbled by 92.06% to $25000.0 in 2022, then soared by 1968.0% to $517000.0 in 2023, then rose by 2.71% to $531000.0 in 2024, then decreased by 0.56% to $528000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Depreciation & Amortization (CF) are $528000.0 (Q3 2025), $529000.0 (Q2 2025), and $531000.0 (Q1 2025).